Skip to content
Home/Companies/MedTech/Perfectus Biomed Group
PB

Perfectus Biomed Group

MedTech·UK·Exited 2022·Held 9yr

Perfectus Biomed Group is a MedTech company, headquartered in UK.

Entry
2013
Hold
9yr
Exit
2022
Est. EV
–

Who owns Perfectus Biomed Group?

Perfectus Biomed Group was owned by River Capital through NW Fund for Biomedical (2010 vintage) from 2013 to 2022, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-06-30

River Capital
Investor
River Capital
NW Fund for Biomedical · 2010 · Healthcare

Key facts

HQUK
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2022

More from NW Fund for Biomedical

Other portfolio companies in the same fund.

Alderley Analytical
Exited 2024
HealthcareUK· 2015
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Aflo
Active
Clarendon Fund ManagersUnited Kingdom
Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Data refreshed weekly · Sourced from public filings